The top 1% of
scientific discoveries.scientific discoveries.
PubMed publishes a flood of biomedical research every day. ElixirFeed screens it, scores it, and summarizes only the papers most likely to matter.
Impact screening
Most papers are not worth your time
ElixirFeed is built around selection first and summarization second. We scan broad biomedical output, rank it by evidence and relevance, then explain the few papers that clear the bar.
Top-1% selection
We score every eligible PubMed candidate for a publication date and only enrich the highest-impact papers.
Evidence-weighted ranking
Randomized trials, meta-analyses, large human studies, novelty, public relevance, and clinical impact count more than hype.
Translations
Summaries and related content are available in:
- 🇺🇸 English
- 🇪🇸 Spanish
- 🇵🇱 Polish
- 🇵🇹 Portuguese
Broad biomedical coverage
Browse discoveries across human health, disease, medical innovation, fundamental science, and public health.
Readable study briefs
Each selected paper gets a plain-language summary, what we know and do not know, an actionable takeaway, and a short glossary.
Weekly signal digest
Get a compact email with the strongest recent papers, not a long list of everything that matched a keyword.
Why this exists
PubMed is comprehensive. Newsletters are selective. ElixirFeed is scored.
The feed is designed for readers who want a daily research signal without turning discovery into a manual literature-review job.
Excellent for searching once you know what you need, but every result still has to be triaged manually.
Readable, but coverage depends on one curator's interests and may miss important papers outside that lane.
Screens broad PubMed output, scores candidates consistently, and explains only the papers that clear the bar.
Example selected profile
Papers that reach the feed usually have strong scores across several signals. Prestige helps, but cannot rescue weak evidence.
Pipeline
From PubMed firehose to a short, ranked feed
ElixirFeed starts broad, removes papers without useful abstracts, screens titles, scores evidence and relevance, then enriches only the top-ranked studies with summaries, categories, visuals, and translations.
From paper flood to readable signal
The feed is intentionally sparse. When a paper makes it through screening, the card shows why it matters and what uncertainty remains.
Ultrasound-Guided Fibrinolysis Reduces Pulmonary Embolism Risks
This clinical trial compared catheter-directed fibrinolysis plus anticoagulation with anticoagulation alone in adults with intermediate-risk pulmonary embolism. The intervention reduced short-term serious events, while bleeding risk and long-term outcomes still need careful follow-up.
Who is ElixirFeed for?
Curious readers who want scientific signal without tracking PubMed all day
Clinicians, founders, and researchers who need quick awareness of major biomedical findings
Health-focused people who want evidence quality clearly separated from hype
Pricing
Start free, upgrade when ElixirFeed becomes part of your routine
Standard is free for signed-in readers. Pro unlocks the full archive and the features that make the feed personal.
Standard
Free forever
- Limited recent feed access (3 articles)
- English summaries
- Bookmarks, votes, and comments
- No weekly email digest
- No category preferences or translations
Pro
Full research feed
- Full feed archive
- Article detail access for all ingested papers
- Weekly digest email
- Bookmarks, votes, and comments
- Category preferences and animal-study preference
- Translations
Visitors who are not signed in see a curated three-article preview selected by the editor.
Research workflows
Use ElixirFeed as a biomedical research filter
Different readers come to the same problem from different searches: PubMed ranking, clinical updates, biotech monitoring, or broad research triage.
Open the feed that already did the filtering
Read the strongest biomedical papers of the day in plain language.